147 related articles for article (PubMed ID: 18520779)
1. Lithium treatment decreases activities of tau kinases in a murine model of senescence.
Tajes M; Gutierrez-Cuesta J; Folch J; Ferrer I; Caballero B; Smith MA; Casadesus G; Camins A; Pallás M
J Neuropathol Exp Neurol; 2008 Jun; 67(6):612-23. PubMed ID: 18520779
[TBL] [Abstract][Full Text] [Related]
2. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
[TBL] [Abstract][Full Text] [Related]
3. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
[TBL] [Abstract][Full Text] [Related]
4. Lithium inhibits Abeta-induced stress in endoplasmic reticulum of rabbit hippocampus but does not prevent oxidative damage and tau phosphorylation.
Ghribi O; Herman MM; Savory J
J Neurosci Res; 2003 Mar; 71(6):853-62. PubMed ID: 12605412
[TBL] [Abstract][Full Text] [Related]
5. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
Takahashi M; Yasutake K; Tomizawa K
J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
[TBL] [Abstract][Full Text] [Related]
6. Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta.
Kitazawa M; Trinh DN; LaFerla FM
Ann Neurol; 2008 Jul; 64(1):15-24. PubMed ID: 18318434
[TBL] [Abstract][Full Text] [Related]
7. Role of glycogen synthase kinase-3β in ketamine-induced developmental neuroapoptosis in rats.
Liu JR; Baek C; Han XH; Shoureshi P; Soriano SG
Br J Anaesth; 2013 Jun; 110 Suppl 1():i3-9. PubMed ID: 23533250
[TBL] [Abstract][Full Text] [Related]
8. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
[TBL] [Abstract][Full Text] [Related]
9. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease.
Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F
Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096
[TBL] [Abstract][Full Text] [Related]
10. Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM).
Canudas AM; Gutierrez-Cuesta J; Rodríguez MI; Acuña-Castroviejo D; Sureda FX; Camins A; Pallàs M
Mech Ageing Dev; 2005 Dec; 126(12):1300-4. PubMed ID: 16171847
[TBL] [Abstract][Full Text] [Related]
11. Kainate-induced toxicity in the hippocampus: potential role of lithium.
Crespo-Biel N; Camins A; Canudas AM; Pallàs M
Bipolar Disord; 2010 Jun; 12(4):425-36. PubMed ID: 20636640
[TBL] [Abstract][Full Text] [Related]
12. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
[TBL] [Abstract][Full Text] [Related]
13. Lithium inhibits stress-induced changes in tau phosphorylation in the mouse hippocampus.
Yoshida S; Maeda M; Kaku S; Ikeya H; Yamada K; Nakaike S
J Neural Transm (Vienna); 2006 Nov; 113(11):1803-14. PubMed ID: 16855914
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells.
Yeste-Velasco M; Folch J; Trullàs R; Abad MA; Enguita M; Pallàs M; Camins A
Neuropharmacology; 2007 Aug; 53(2):295-307. PubMed ID: 17612578
[TBL] [Abstract][Full Text] [Related]
15. S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.
Won JS; Annamalai B; Choi S; Singh I; Singh AK
Brain Res; 2015 Oct; 1624():359-369. PubMed ID: 26271717
[TBL] [Abstract][Full Text] [Related]
16. Lithium blocks ethanol-induced modulation of protein kinases in the developing brain.
Chakraborty G; Saito M; Mao RF; Wang R; Vadasz C; Saito M
Biochem Biophys Res Commun; 2008 Mar; 367(3):597-602. PubMed ID: 18190791
[TBL] [Abstract][Full Text] [Related]
17. Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies.
Nakashima H; Ishihara T; Suguimoto P; Yokota O; Oshima E; Kugo A; Terada S; Hamamura T; Trojanowski JQ; Lee VM; Kuroda S
Acta Neuropathol; 2005 Dec; 110(6):547-56. PubMed ID: 16228182
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells.
Lee KY; Koh SH; Noh MY; Park KW; Lee YJ; Kim SH
Brain Res; 2007 Jan; 1129(1):89-99. PubMed ID: 17157278
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation.
Zhang YJ; Xu YF; Liu YH; Yin J; Wang JZ
FEBS Lett; 2005 Nov; 579(27):6230-6. PubMed ID: 16253246
[TBL] [Abstract][Full Text] [Related]
20. Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways.
Hu JP; Xie JW; Wang CY; Wang T; Wang X; Wang SL; Teng WP; Wang ZY
Brain Res Bull; 2011 May; 85(3-4):194-200. PubMed ID: 21435383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
